Protection against stary risk - Latest News Update, Information, Photos & Videos on Protection against stary risk at Lokmat Times

The Mexico Federal Commission for the Protection Against Stary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin."The decision by Cofepris to authorize the emergency use of the Covaxin vaccine produced in India was made very timely. Mexico's COVID-19 vaccination opportunities are expanding," Mexican Foreign Minister Marcelo Ebrard said in a tweet.Since the beginning of the vaccination campaign, the Mexican authorities have distributed over 9.6 million doses of vaccines, mainly among the elderly and doctors. The massive campaign began in the second half of February, reported Sputnik.Currently, there are five different vaccines that are being used in Mexico, either purchased from abroad or produced locally--Pfizer/BioNTech, Oxford/AstraZeneca, Sinovac, Cansino, and Sputnik V.According to Johns Hopkins University, Mexico has a total of 2,256,509 COVID-19 cases. As many as 204,985 people have died so far in the country.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

Salman Khan

Protection Against Stary Risk, NewsFOLLOW

Protection against stary risk, Latest News

International :Mexico grants authorisation for emergency use of India's COVID-19 vaccine, Covaxin

The Mexico Federal Commission for the Protection Against Sanitary Risk (Cofepris) on Wednesday has granted authorization for the emergency use of India's first domestically-produced COVID-19 vaccine, Covaxin. ...